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Abstract
Title: Implementing a Patient Reported Outcome Measure for Patient with Anemia of Chronic
Kidney Disease (CKD) in the Outpatient Setting.
Introduction: Chronic kidney disease (CKD) is a growing public health concern in the United
States. People with CKD suffer from many symptoms that cause distress and low quality of life
(QoL). Research has found an association between symptom burden in patients with CKD and
the disease's worsening progression. There is little data on ways to monitor and address CKD
symptoms routinely.
Purpose: The purpose of this project was to identify symptoms related to advancing kidney
disease using patient-reported outcome measures (PROMs) through IPOS-Renal survey and
implement a nurse-driven protocol to manage patient reported symptoms.
Interventions/Setting: Over a three-month period at the outpatient nephrology clinic in Boston,
Massachusetts, patients completed the IPOS-Renal survey before their appointment with the
renal nurse to assess uremic symptoms. Once the IPOS-Renal survey was conducted, the nurse
evaluated the survey and implemented the agreed-upon interventions. The patients were then
asked to fill out another IPOS-Renal survey before their next visit to see if the interventions were
effective and whether they had new symptoms that needed to be addressed.
Evaluation: A total of 23 patients were eligible for the QI project. The final analysis included
survey data from nine patients who completed both IPOS-Renal surveys. 50% of patients who
reported pain, SOB, nausea, poor appetite, constipation, and, itching had full resolution of
symptoms after interventions. Patients with weakness/lack of energy had 40% complete
resolution and 20% had symptom improvement. Patients who reported drowsiness, 75% reported
complete resolution their symptoms. 40% of paints reported improvement of difficulty sleeping.
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100% of patients who reported restless leg syndrome and diarrhea reported resolution of
symptoms after interventions.
Discussion: Implementing PROMs is allows for a standardized way to assess, treat, and monitor
symptoms associated with CKD and ESRD. The results showed benefits to having a consistent
way to evaluate, manage, and monitor symptoms of CKD. This protocol also has the potential to
be used as a metric on whether the patient needs to start dialysis.
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Problem Identification, Development of Clinical Question, and Evidence Review
Background and Significance of Problem
Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are a growing public
health concern in the United States. The Centers for Disease Control (CDC) estimates that 37
million US adults have CKD. It is the ninth leading cause of death. Not only is the number of
patients affected by this disease growing, but so is the cost to manage this disease. Medicare
spends $84 billion on CKD management and $36 billion on ESRD (Leventhal, 2021).
Decreasing the number of patients who progress to ESRD and improving outcomes for people
living with CKD can reduce this cost by reducing hospital admissions.
People with CKD and ESRD suffer from many symptoms that cause distress and low
quality of life (QoL). These symptoms include fatigue, shortness of breath, pruritus, loss of
appetite, sleep disturbances, nausea, vomiting, constipation, low mobility, and lack of energy.
According to Brown et al. (2017), there is an association between symptom burden in patients
with CKD stages 1-5 and the disease's worsening progression. It is essential to recognize and
understand the factors that impact these patients' QoL in treating CKD because interventions
could reduce their symptom burden and increase their QoL (Krishnan et al., 2020).
Description of Local Problem
Many patients at a local, non-profit hospital with advanced chronic kidney disease
develop anemia due to the lack of production of a hormone called erythropoietin, or EPO. EPO is
a hormone released by the kidney that signals the bone marrow to make red blood cells (RBCs)
(NIDDK, 2020). After a failed trial with iron supplements, patients with anemia are referred to
the renal nurse to receive an erythropoietin-stimulating agent (ESA).
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During the ESA appointments, the renal nurses are supposed to assess for uremic and
anemia symptoms to monitor their CKD progression. At a local, non-profit hospital, there is no
process for the renal nurse to monitor and manage the patient’s reported symptoms
independently. This leads to inaccuracies in the assessment of those symptoms.
Organization Priority:
This project has the support of the Renal Clinic Director, and Chief of Ambulatory
Nephrology. The Medical Specialities director, also supports this initiative. The clinic
nephrologists also supported this initiative.
Focused Search Question
In patients with advanced chronic kidney disease (P), how does the use of patientreported outcome measures through the IPOS-Renal survey (I), compared to not utilizing
standardized assessments (C), affect symptom burden and quality of life (O)? This type of PICO
question used for this project is intervention. Randomized controlled trials (RCT) and systematic
reviews of a single RCT are appropriate for consideration in answering this type of question.
Though, given the lack of abundant evidence at this level, lower levels of evidence were used.
This evidence consisted of observational studies.
Evidence Search
External Evidence. CINAHL and Medline databases were searched. The keywords
searched were chronic kidney disease or chronic renal failure or CKD or ESRD, chronic kidney
disease and education, chronic kidney disease and emergent dialysis, chronic kidney disease or
chronic renal failure or CKD or ESRD and education, chronic renal failure, or CKD or ESRD
and renal replacement therapy, chronic renal failure, or CKD or ESRD and renal replacement
therapy and education, and chronic renal failure or CKD or ESRD and patient satisfaction.
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Limits and filters for all searches included the English language full-text articles published
between 2015 and 2021. See Appendix I; Tables 1 and 2 displace the database, search terms, and
research results.
Internal Evidence. The outpatient renal and float nurses were surveyed for their current
practices to evaluate their assessment and management of advanced chronic kidney disease and
anemia symptoms. It was found that there was no process or procedure in place for the nurse to
ask patients about their uremic symptoms. Since there was no process in place, nurses would
often forget to ask about each of the uremic symptoms. There was also no system or protocol for
the nurses to evaluate, treat, and monitor individual patients’ symptoms. The management of the
patient’s symptoms relied entirely on the physician. These responses from the nurses suggested
the need for a standardized nurse-driven protocol to make autonomous care decisions and foster
efficiency in care delivery.
Evidence Appraisal, Summary, and Recommendations
Five articles focusing on utilizing patient-reported outcome measures (PROMs) to
improve patient outcomes were reviewed. The level of evidence for the five studies was a mix of
level one, systematic review or meta-analysis, and level five, cohort studies, see Appendix II for
evidence summary. The studies found that PROMs assessments were associated with improved
patient satisfaction, increased self-management of chronic disease, decreased symptom burden,
enhanced health literacy, and improved quality of life. Additionally, studies found having nurseled disease management programs in CKD may improve some quality-of-life parameters. The
IPOS-Renal survey was chosen as the PROMs tool for this project because it was found to have
good test-retest reliability, internal consistency, and construct validity in patients with CKD (Raj
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et al., 2018), see Appendix XII. Based on this evidence, the recommendation is to implement
IPOS-Renal assessment in the outpatient CKD clinic to improve patient care and outcomes.
Project Plan
Project Objectives
1. Reduce symptom burden in patients with CKD stage 4/5 on EPO
2. Improve patient satisfaction with their care
3. Improve patient-provider communication
4. Increase hospital revenue through reimbursements from Medicare and Medicaid
Project Goals
1. Identify symptoms related to advancing kidney disease using PROMs through IPOSRenal.
2. Implement a nurse-driven protocol to manage patient-reported symptoms.
Context
This non-profit hospital is part of an integrated healthcare system with several nephrology
departments. The setting of this quality improvement project would be in an outpatient renal
medicine department. Participants will include adult patients with CKD stage IV/V defined as GFR
<30 receiving EPO from the renal nurse.
Key Stakeholders
Director of KidneyPal Outpatient Program; Clinical Chief of Renal Division; director of
Renal Division; nephrologists of patients receiving EPO. Renal nurse and Float Renal Nurses.
Framework
The Plan-Do-Study-Act cycle is the recommended tool of the Institute for Healthcare
Improvement when testing a real work environment change. The PDSA allows for the
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development of a plan to test the change (Plan), execution of the plan (Do), observations and
learnings from the results (Study), and modifications to make the plan more efficient (Act) (IHI,
n.d.). As discussed, this project aims to decrease the symptom burden of patients with advanced
CKD receiving EPO. The PDSA cycle for this QI project is outlined below (see Appendix III).
Plan Phase. The DNP student met with one of the nephrologist to create a protocol to
monitor and manage advancing CKD and anemia symptoms utilizing provider input and approval.
The interventions were also sent to the Chief of Ambulatory Nephrology, and the Director of
Ambulatory Nephrology. A Smart Phrase was designed in order to standardize documentation for
each nurse (Appendix VI). The PROMs, IPOS-Renal, survey was integrated into an electronic
version that can be sent to patients via their patient portal. Project goals #1 and #2 will be addressed
in this phase.
Do Phase. In this phase, the clinic and float nurses were introduced to the plan and educated
on how to use the Smart Phrase, what the plan of care is for each symptom reported, and how to
send the survey on the patients’ Patient Gateway (PGW) portal by the DNP student. The IPOSRenal survey will be sent to the PGW portal to fill out prior to their EPO injection appointment.
The nurses will review the survey and have an individualized plan of care in place for the patients
to review during their EPO appointment. Verbal feedback will be gathered by the DNP student
from the renal nurses, providers, and patients on the updated nurse-led protocol.
Study Phase. Process measures include analyzing the IPOS-Renal surveys to compare
symptom burden pre- and post-interventions. During the study phase, the DNP student also
adjusted the symptom management and clinic processes based on patient and staff feedback.
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Act Phase. In this phase, the recommendations would be modified as needed to decrease
symptom burden based on provider and patient input. There would also be an adjustment to how
the surveys are sent out and interpreted based on nurse and patient feedback.
Barriers to Implementation/Sustainability
Barriers to implementation include increasing appointment time for the patients. This is
due to the nurse having the patient complete it during their appointment, assessing the survey, and
discussing the treatment modalities with the patient. This also increases the workflow for the nurse,
which is not ideal. There is only one full-time nurse in the renal department who also has to triage
and answer portal messages. Additional barriers may include training the float nurses to assess the
survey results and utilize the Smart Phrases when the regular renal nurse is not there. Another
impediment to implementation is that the providers may be unwilling to support a nurse-driven
protocol to manage patient symptoms. Providers may also feel under scrutiny for not effectively
managing their patients' symptoms (Zhang et al., 2019). Additional implementation challenges
include patients' inability to complete the electronic IPOS-Renal survey due to age, computer
literacy, access to the internet, and the burden of completing the survey multiple times (Elliot et
al., 2019).
Plans to address these deterrents involve creating a paper survey if a patient meets the
criteria but does not have Patient Gateway. There were also be plans to educate providers that
PROMs individualize patient care and allow for the close monitoring of symptom burden and have
been successful in enhancing provider-patient communication and patient satisfaction with care.
Furthermore, providers will be reassured they are the individuals who approve the interventions
on a patient-to-patient basis. Another way to address these limitations is to assure providers that
this will not increase their workload since it is a nurse-driven protocol. Lastly, the float nurses and
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new renal nurses will be educated on the significance of individualizing patient care and improving
patient outcomes, so they are willing to participate in this initiative.
Dissemination
There are many nephrology departments within the integrated healthcare system. Internal
and external dissemination of PROMs use in decreasing symptom burden efforts is crucial in
facilitating the transfer of the findings from this QI initiative (Melnyk et al., 2019). Every
Tuesday and Thursday at MGB, there are Renal Grand Rounds with invited international
speakers who discuss current clinical research in nephrology (BWH, n.d.). During the Grand
Rounds, an EBP presentation demonstrating the effects and outcomes of utilizing PROMs to
monitor symptom burden and implement modalities based on results would be highlighted
(Cullen et al., 2017). The presentation of these findings on a platform as wide-reaching as the
Renal Grand Rounds would disseminate the information and provide others with resources to
utilize and implement this practice in their organization.
MGB's weekly newsletters will also serve an essential role in conveying the findings to
other departments. A brief summary of project findings will be mentioned in this newsletter to
report the QI initiative's pilot results to help gain other units' interest (Cullen et al., 2017).
Increased visibility would allow every employee to monitor the initiative's effectiveness in the
outpatient CKD clinic. At the end of the newsletter, the project leader and supervisor's contact
information would be listed for employees to reach out for more details.
Estimated Timeline
The project timeline begins with completing the project proposal draft, completing the
DNP project proposal to present to stakeholders, obtaining their approval to implement the project,
implementing the project in the renal clinic, adjusting the project based on the PDSA cycle,
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tracking outcome measures, and ends with presenting and submitting the final DNP project, see
Appendix IV for estimated dates.
Resources
Table III describes the anticipated costs of project implementation and evaluation. The
Project Manager will spend approximately 5% of time managing the entire project over four
months, about 24 hours per month. The duties fulfilled by the Project Manager include
implementation of the project, creation of a plan of care document, data collection, creating a Red
Cap survey to track data, training of nurses, and evaluating survey responses. The IT support will
spend 1% of time helping to guide DNP students through making Smart Phrases for
documentation, survey support, and Red Cap support. Additional support includes printing the
IPOS-Renal surveys for patients who meet the criteria but do not have a patient portal activated to
complete surveys.

Review for Ethical Consideration
Quality improvement projects are not required to obtain IRB (Institutional Review
Board) review by the hospital, per their Clinical Quality Improvement/Measurement Checklist,
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see Appendix V. This project was deemed as a QI project buy the Ambulatory Nursing Director,
Rossana Encalada, DNP, RN, NEA-BC.
Project Implementation
Create Awareness and Interest
In phase I of the implementation strategy, it is essential to highlight the advantages and
anticipated impact of the quality improvement initiative (Cullen et al., 2017). Currently, at the
hospital, the renal nurse monitors the progression of the patients’ chronic kidney disease and
anemia symptoms by asking them questions at every appointment. However, the renal nurse
cannot provide treatment modalities to help alleviate those symptoms. Additionally, the
providers at the hospital are only in the clinic 1-2 days a week, so non-emergent messages may
take up to 72 hours to receive a response. The potential stakeholders would be made aware of
this fact during the presentation. The positive aspects of implementing a nurse-based protocol to
handing CKD symptoms would be brought to the stakeholders’ attention. Some favorable
aspects would be having the nurse monitor the patient’s symptoms at every EPO appointment to
implement care that would help alleviate the patient’s symptoms, which will increase the
patient's satisfaction with their care.
Highlighting the anticipated impact of increased patient satisfaction will increase
profitability through reimbursements from Medicare and Medicaid. This incentivizes greater
buy-in from hospital administration (Richter & Muhlestein, 2017). Medicare and Medicaid have
moved to value-based programs and reimburse providers for providing quality care to patients
(CMS, 2020). One metric that Medicare and Medicaid use to measure health care quality is
patient satisfaction, which would relate to this quality improvement initiative.
Build Knowledge and Commitment
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Phase II of the implementation strategy builds knowledge and commitment through
education and links the project to stakeholder priorities (Finger, 2020). During monthly nursing
huddles, the float nurses would be educated on the importance of evaluating the IPOS-Renal
survey and using the Smart Sets to help manage their patients’ symptoms. This discussion would
identify gaps in the current practices and highlight the float nurses’ roles in this process (Cullen,
2015).
Along with providing the education, there would also be face-to-face training for the float
nurses to review the new material and provide feedback to the primary renal nurse. Including all
the nurses in the project refinement process will increase ownership and engagement in this
initiative. According to Mathieson, Grande, and Luker (2018), when nurses deem evidencebased practice beneficial and can envision a positive impact on the patient, they are more likely
to support the implementation.
Linking the project to stakeholder priorities allows for a sense of importance in
implementing the practice change (Cullen et al., 2017). Part of the mission statement at this
hospital is to improve patient satisfaction scores and patient experience through leadership in
compassionate care, scientific discovery, and education (BWH, n.d.). This movement would
directly correlate with the quality improvement initiative to improve patient satisfaction through
the standardization of education provided to the patient. Recently, the renal clinic employed a
renal palliative provider. This provider has expressed interest in updating and improving
practices within the renal clinic to add another layer of support to patients by destigmatizing the
word “palliative.” For example, as CKD progresses, many of the patients receiving EPO report a
wide variety of symptoms they are struggling with. However, patients do not want a referral to
palliative care because they associate that word with dying. Part of the protocol would include
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referrals to palliative care, and the patients would be educated on why the referral was being
made and the benefits of having this extra layer of support.
Promote Action and Adoption
Reporting progress directly to colleagues and implementing leadership rounds will help
aid Phase III's implementation strategy by creating incentives and enthusiasm for adopting the
initiative (Cullen et al., 2017). Sending a monthly email to the stakeholders would provide
transparency on the impact of this project. The email would include the number of patients who
completed the IPOS-Renal survey, their scores, and the scores of the repeat IPOS-Renal survey
that would show whether the implementations were leading to a decrease in patient symptom
burden.
Utilizing leadership rounds would allow the providers to implement the new practice
change, troubleshoot, and reinforce the recent practice change (Cullen et al., 2017). The lead
renal nurse and project manager would conduct rounds to assess the float nurses’ competency in
implementing the new initiative. All questions would be answered, and additional training and
direction would be provided if needed. This would support the nurses during the implementation
of the quality initiative.
Pursue Integration and Sustained Use
The final phase of the implementation strategy is to pursue integration and sustained use
of the practice change (Cullen et al., 2017). Trended results are one way that would be utilized to
encourage shared accountability and provide transparency of results (Cullen et al.). Pre/post data
would help show the patient symptom burden trends throughout the implementation process. The
reports would continue monthly, and stakeholders would be encouraged to provide feedback on
the project.
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Celebrating progress is one strategy to encourage clinicians to maintain the practice
change. It allows the staff involved with the achievement to acknowledge that they partook in
making a positive change (AAFP, n.d.). After observing a decrease in symptom burden and
improved patient satisfaction, employees would be rewarded with a celebratory luncheon. Food
and soft beverages will be provided for the staff who can attend catered by a local restaurant. All
stakeholders will be invited to join the celebration.
Evaluation
Process Measures
The process measures include data collected from the electronic medical record (EHR
(Electronic Health Record)) to describe the patient population, including eGFR, and whether
they are receiving erythropoietin stimulating agent (ESA) for chronic kidney disease. The
eligible patients for this QI project included patients 18 years or older, having chronic kidney
disease, being seen by the renal nurse for ESA shots that had an eGFR <30 in the outpatient renal
medicine clinic. Out of 23 eligible patients, 14 patients completed the pre-IPOS-Renal survey.
Out of those 14 patients, nine patients completed the post-IPOS-Renal survey. For the results to
be accurate, five pre-surveys were discarded because there would be no data to from the postintervention IPOS-Renal survey to compare against.
Outcome Measures
According to the IHI (n.d.), the process measures are used to indicate how well an
intervention is functioning and adhering to the model that it is based on. For this quality
improvement project, the process measures are the IPOS-Renal survey before the interventions
are incorporated into the patients’ care plan compared to the post-IPOS-Renal survey. The renal
nurse evaluated both surveys to assess whether there were improvements in the patients’
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symptom burden based on the interventions implemented by the nurse. In the pre-intervention
survey, the most reported symptoms were weakness/lack of energy and difficulty sleeping (n=5).
In the post-survey, the most reported symptom was weakness/lack of energy (n=5). Of the writein area of the IPOS-Renal survey (n=18), there were 61.1% of missing answers, see Appendix
VIII. 83.3% of patients reported they have had as much information as they wanted, 11.1% of
patients wrote sometimes they have as much information as they wanted, and 5.6% of patients
reported not at all that they had as much information as they wanted.
When looking at individual symptoms and patient improvement, patients reported pain
(n=4) in the pre-intervention 50% of patients reported an improvement in their pain after
interventions; see appendix VI for interventions applied to the patients. The other 50% report
they had complete resolution of their pain at the next visit when comparing pain to their first
visit.
Looking at the shortness of breath (n=4), 50% of patients had improvement when
comparing their pre-intervention survey to post-intervention survey. 25% of patients reported
going from moderately affecting them to slighting affecting them. 25% of patients improved
from slightly affecting them to not at all. 50% of patients were unchanged in how much
shortness of breath influenced them.
Five patients reported weakness/lack of energy during the pre-intervention survey. Of
those five patients, 40% reported weakness/lack of energy was not affecting them anymore. 20%
had improvement in their weakness/lack of energy reporting on the pre-intervention survey
severely affecting them, and on the post-intervention survey, it was moderately affecting them.
40% of patients reported their weakness/lack of energy worsened, going from slightly to
moderately.
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Of the patients who reported nausea (n=2), 50% conveyed that their nausea was entirely
resolved, and 50% reported their nausea stayed consistent. The patient that reported their nausea
remained unchanged had other comorbidities affecting it, which may have played a role. One
patient also reported vomiting was affecting them slightly in the pre-intervention survey, but
there was no improvement in the post-intervention survey. For poor appetite (n=2), 50% of
patients reported no change and 50% reported complete resolution. Constipation (n=2), 50%
reported full resolution and 50% remained consistent. Patients who reported diarrhea (n=1) on
the pre-intervention survey had a complete resolution on the post-intervention survey.
The patient who reported on the pre-intervention survey that they were experiencing dry
mouth (n=1) was slightly affecting them over the last week reported it was not at all affecting
them on the post-intervention survey. However, two patients in the post-intervention survey
reported that they were now experiencing sore/dry mouths.
Of patients who reported drowsiness (n=4), 75% of them reported complete resolution of
their symptoms. 25% reported that their drowsiness remained the same after the interventions. Of
poor mobility (n=4), 50% reported improvement in their symptoms after interventions. 25%
reported worsening symptoms, reporting poor mobility was moderately affecting them over the
past week to severely affecting them over the past week. 25% reported no change in mobility. On
the post-intervention survey, a patient who reported mobility was not affecting them now
reported it was affecting them moderately.
Four patients reported that itching was affecting them. Of those four patients, 50% had
resolution of symptoms after interventions. 50% of patients reported no change in their
symptoms after interventions. Patients who reported changes in their skin (n=1) reported
resolution of symptoms on the post-survey.
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Of patients who reported difficulty sleeping (n=5), 40% of patients reported improved
symptoms after interventions were applied. 40% of the patients report worsening symptoms, both
going from slightly to moderately. 20% of those five patients reported that their symptoms
affected them moderately both before and after interventions were applied.
Restless leg syndrome (n=1) reported complete resolution of their restless leg syndrome
after interventions were applied. Two patients who reported no restless leg syndrome on the first
survey reported it on the follow-up survey.

Table 2.
Symptoms
Pain
Shortness of Breath (SOB)
Weakness/Lack of Energy
Nausea
Vomiting
Poor Appetite
Constipation
Sore/Dry Mouth
Drowsiness
Poor Mobility
Itching
Difficulty Sleeping
Restless Leg Syndrome
Changes in Skin
Diarrhea

Pre-Intervention Survey
(n=9)
4
4
5
2
1
2
2
1
4
5
4
5
1
1
1

Post-Intervention Survey
(n=9)
2
3
5
1
1
1
1
2
1
4
3
4
2
0
0

Return of Investment
This project focused on a protocol set to manage patients’ CKD and anemia. Overseeing
these symptoms as they arise allowed patients to avoid emergency room (ER) visits. After the
completion of a chart review, it was found that on average four interventions were applied for
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each patient who reported a symptom that was bothering them. These interventions included
further labs to evaluate their symptoms, additional assessments, non-pharmacologic
interventions, or over-the-counter medication recommendations.
Additionally, the average ER visit in the state of Massachusetts costs approximately
$1,000 (Benedict et al., 2021). Suppose all nine patient’s symptoms worsened and necessitated a
visit to the ER, that would cost the hospital approximately $9,000. By providing interventions to
avoid the ER, after subtracting costs of implementing this project, the hospital would net
$2,893.01 in profits. Positive patient experiences can also lead to a better reputation. If patients
are satisfied with the care they are receiving, they are more likely to recommend the hospital to
friends and family. This would increase appointments made at this hospital in Boston due to
personal referral.
Barriers Encountered During Implementation
One barrier faced was how the patients were completing the survey. The IPOS-Renal
survey was meant to be completed electronically before patients’ appointments. However, there
were barriers to achieving this, such as lack of computer literacy, language barriers, and no
patient portal activation. Approximately 29% of patients completed the pre-survey electronically
before their appointment, see Table 3. Of the patients who completed the pre-survey, only 11%
finished the post-survey. To account for this, if the patient had not filled out their survey prior to
their appointment, the nurse would provide them with the survey and offer to complete it with
them. This was very time-consuming because the nurse would evaluate the responses then
implement the care plan. This increased appointment times by 33%.
Another significant barrier that was experienced in this project was survey fatigue. It was
meant to have a survey to re-evaluate patients’ symptoms at every visit. However, the patient did
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not want to keep completing surveys. If the patient had completed more than two surveys, there
would have been a better understanding of the effectiveness of the interventions applied to the
symptoms. It also caused a small sample size because not all the patients who were eligible
completed the survey.
Staffing was also a hurdle during implementation. One primary renal registered nurse ran
the project due to the lack of staff in the outpatient renal clinic. The three ambulatory float nurses
did not cover the renal clinic during this time. One renal/GI float nurse was hired during this
project but felt it was too complex to contribute to before she felt comfortable in the clinic. This
limited the amount of support during the project. It also skewed whether this would have been a
sustainable project.
Table 3.
How the IPOS-Survey Was Completed

Assistance from Nurse
Independent in Clinic Prior to Appt
Electronically Prior to Appt.

Pre-IPOS Renal Survey
(n=14)
4
6
4

Post-IPOS Renal Survey
(n=9)
4
4
1

Dissemination
Implications of Project Results to Organization and Practice
The results demonstrated the benefits of having a nurse-driven protocol to manage
chronic kidney disease and anemia symptoms for most symptoms. The surveys help to manage
the patients’ most bothersome symptoms and assist the provider in knowing when the patient is
approaching the need for dialysis. For the initiation of dialysis, nephrologists look at the patients’
eGFR and their subjective symptoms. Patients with severe chronic kidney disease show an
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increase in their subjective symptoms such as SOB, fatigue, muscle cramps, nausea, vomiting,
etc. The provider can use that information as rationale data to initiate dialysis.
Sustainability plan
Plans to sustain this QI project include shortening the survey and incorporating this
project in the nurse onboarding process. There will be an increase in staffing for the outpatient
renal department, so if a new hire is taught this as protocol and procedure, it will be part of their
routine. This is very specific to the renal medicine department because there are plans to hire
more renal nurses to account for the growing department. Another way to sustain this change
would be to complete chart reviews and provide data on how many patients were initiated on
dialysis from their IPOS-Renal survey scoring.
Conclusion
Implementing a PROM survey for patients in the renal department has many benefits,
such as close monitoring of uremic symptoms to indicate that the start of dialysis is near. Early
management of those symptoms to increase patient satisfaction and communication with their
providers. Increased revenue from reimbursement of insurance and referrals from increase in
satisfied patients with their care.
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Appendix I: Evidence Search
Table 1.
CINAHL Complete Search Terms and Search Results
Search Terms

Number of hits Number of
title & abstract
reviewed

Chronic kidney
disease or chronic
renal failure or ckd
or esrd
Chronic Kidney
Disease and
Education
Chronic Kidney
Disease and
Emergent Dialysis
Chronic kidney
disease or chronic
renal failure or ckd
or esrd and
education
Chronic kidney
disease or chronic
renal failure or ckd
or esrd and renal
replacement
therapy
Chronic kidney
disease or chronic
renal failure or ckd
or esrd and renal
replacement
therapy and
education
chronic kidney
disease or chronic
renal failure or ckd
or esrd and
education and
patient satisfaction

33,379

Table 2.

Number of
full-text
articles
reviewed

Number of
articles
selected for
this review
without
duplicates

395
4
420

279

50

8

4

144

60

15

11

80

40

10

3

29
Medline Complete Search Terms and Search Results
Search Terms

Number of hits Number of
title & abstract
reviewed

chronic kidney
disease or chronic
renal failure or
CKD or ESRD
Chronic Kidney
Disease and
Education
Chronic Kidney
Disease and
Emergent Dialysis
Chronic kidney
disease or chronic
renal failure or
CKD or ESRD and
education
Chronic kidney
disease or chronic
renal failure or
CKD or ESRD and
renal replacement
therapy
Chronic kidney
disease or chronic
renal failure or
CKD or ESRD and
renal replacement
therapy and
education
chronic kidney
disease or chronic
renal failure or
CKD or ESRD and
education and
patient satisfaction

137,265

Number of
full-text
articles
reviewed

Number of
articles
selected for
this review
without
duplicates

4,934
21

21

4

4

2,322

30

5

1

1,793

40

4

2

148

60

6

4

31

31

4

2

Appendix II: Evidence Summary
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First
Author
(Year)
Ducharle
t (2019)

Aiyegbus
i (2017)

Havas
(2017)

Purpose

Level of
Evidence/Typ
e of Evidence

To examine
relationships
between
symptom
burden, QOL
(quality of
life) and
functional
status and
associations of
symptoms and
mortality risk

Level 5

To evaluate
studies that
assessed the
measurement
properties of
PROMs in
adults with
CKD to see if
they are
suitable for
use in research
or clinical
practice.

Level 1

To evaluate
the benefits of
patientcentered care
in CKD
patients

Level 5
Cross-sectional

A multisite
longitudinal
cohort analysis

Systemic review
with or without
meta-analysis of
randomized
control trials

Sample/Setting

Major
Variables

Article 1:
CKD stage 4/5
Symptom
(no dialysis) and
burden, QOL,
dialysis patients
functional
status,
association of
symptoms,
and mortality
risk

Article 2:
66 articles were
Type or
used in the final
PROMs
analysis that met
being
the criteria.
utilized, the
population
(dialysis, predialysis, and
renal
transplant)

Article 3:
Patients with
CKD, patient
CKD
reported
Cross-sectional
symptoms,
survey identified
desire for
10 areas that
those with CKD
believe require
additional
support.
Descriptive data
were generated,
and MannWhitney U tests
were performed

How
Variables
were
Measured

Findings

Worth t
Practic

Wilcoxon
rank-sum
test,
Spearman’s
rank
correlation
coefficient,
Univariate
Cox
Proportional
Hazards,
POSS Renal

Patients with
advanced
CKD
(Including
dialysis,
patients
managed
conservativel
y without
dialysis or
pre-dialysis)
have
significant
symptom
burden
associated
with reduced
self-reported
QO

There is
reduced self
reporting of
symptom
burden, so i
there were t
in place to
assess symp
burden and
QOL, it cou
help improv
patient
satisfaction.

COSMIN
checklist,
Cohen’s
Kappa
Statistic

KDQOL-36
for use in predialysis
patients; the
KDQOL-SF
or KDQOL36 for dialysis
patients and
the ESRDSCLTM for
use in
transplant
recipients.

This is good
know, so if
want to star
utilizing
PROMs in
practice, the
provider sho
utilize the
specific
PROMs to
match the
population.

SPSS
version 22.
Continuous
data are
presented as
median
(interquartile
range; IQR).
As data
failed
assumptions
of t-tests,
nonparametric

Participants
reported
desiring more
support with
all 10 aspects
of selfmanagement,
with the most
would like
selfmanagement
of developing
and sustaining
a positive

This article
showed that
CKD pts
require
additional
support acro
the selfmanagemen
spectrum, so
providers
should try a
include/eng
the patient t
become acti
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to compare the
desires of diverse
groups of
participants.

Örsal
(2019)

To examine
the
relationships
between health
literacy,
primary care
satisfaction
levels and
health
awareness of
the patients
who were
admitted to
primary care
centers

Level 5
Cross-sectional

Peng
(2019)

To investigate
whether selfmanagement
intervention
improves
renoprotection
for nondialysis
chronic kidney
disease

Level 1
Systematic
review with
meta-analysis of
RCT

Article 4:
cross-sectional
Health
study conducted
awareness
on individuals
and
who were
satisfaction,
admitted to
health
Family Health
literacy
Centers

Article 5:
19 studies with a
Selftotal of 2540
management
CKD patients and intervention
a mean follow-up (lifestyle
of 13.44 months.
modifications
, medicalbehavior
modifications
, and multifactorial
modifications
and CKD
progression.

Appendix III: PDSA Cycle

MannWhitney U
tests were
used.

attitude and
caring for
mental and
physical
wellbeing.

parts of thei
healthcare t
while
empowering
them with th
knowledge
do so.

Turkish
Health
Literacy
Scale (HLSTR), Index
score
calculation
for matrix
components,
Cronbach
Alpha
coefficient

The patients
with an
elevated level
of satisfaction
from
physicians,
healthcare
and health
centers have a
higher health
literacy level
than those
who have a
lower level of
satisfaction.

This is an
important
finding beca
providers
should be
trying to
improve
patients’ he
literacy to h
encourage t
to be active
partners in t
healthcare
team. Also,
Medicare an
Medicaid
moved to a
value-based
reimbursem
so improvin
health litera
will also
improve pat
satisfaction
scores.

Cochrane Q
statistic and
an I2 test,
funnel plot,
Egger’s
linear
regression
test for
dichotomous
data or
Harbord’s
test for
continuous
data.

Selfmanagement
intervention
was beneficial
for changing
modifiable
risk factors
(e.g.,
proteinuria,
blood
pressure
level, blood
glucose level,
exercise
capacity) for
the
progression of
CKD

Providers ca
utilize this
article to he
educate pati
on modifiab
risk factors
help slow th
progression
CKD.
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Appendix IV: Project Timeline

Appendix V: Clinical QI Checklist
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Appendix VI: Plan of Care for Symptom Burden
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Appendix XII: IPOS-Renal Survey
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Appendix XIII: All Data with No Distinction Between Pre/Post Survey
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